United States
Securities and Exchange Commission
Washington, D.C. 20549
FORM 10-Q
| x | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the Quarterly Period Ended September 30, 2004
| ¨ | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the Period from : to
Commission file number 0-22554
OPINION RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware | 22-3118960 | |
| (State of incorporation) | (I.R.S. Employer Identification No.) |
| 600 College Road East, Suite #4100 Princeton, NJ |
08540 | |
| (Address of principal executive offices) | (Zip Code) |
609-452-5400
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes x No ¨
Indicate by check mark whether the Registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2). Yes ¨ No x
Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practical date.
Common Stock, $0.01 Par Value 6,310,971 shares as of October 29, 2004.
Opinion Research Corporation and Subsidiaries
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
OPINION RESEARCH CORPORATION AND SUBSIDIARIES
Consolidated Balance Sheets
(in thousands, except share amounts)
| December 31, 2003 |
September 30, 2004 |
|||||||
| (Unaudited) | ||||||||
| Assets | ||||||||
| Current Assets: |
||||||||
| Cash and cash equivalents |
$ | 2,766 | $ | 15 | ||||
| Accounts receivable: |
||||||||
| Billed |
24,890 | 23,410 | ||||||
| Unbilled services |
14,140 | 18,580 | ||||||
| 39,030 | 41,990 | |||||||
| Less: allowance for doubtful accounts |
336 | 268 | ||||||
| 38,694 | 41,722 | |||||||
| Prepaid and other current assets |
3,161 | 3,990 | ||||||
| Total current assets |
44,621 | 45,727 | ||||||
| Property and equipment, net |
9,099 | 9,767 | ||||||
| Intangibles, net |
715 | 459 | ||||||
| Goodwill |
32,537 | 32,579 | ||||||
| Deferred income taxes |
4,417 | 4,404 | ||||||
| Other assets |
4,322 | 3,050 | ||||||
| $ | 95,711 | $ | 95,986 | |||||
| Liabilities and Stockholders Equity | ||||||||
| Current Liabilities: |
||||||||
| Accounts payable |
$ | 5,473 | $ | 5,394 | ||||
| Accrued expenses |
13,829 | 11,718 | ||||||
| Deferred revenues |
2,183 | 3,388 | ||||||
| Short-term borrowings |
3,000 | 2,000 | ||||||
| Other current liabilities |
762 | 2,152 | ||||||
| Total current liabilities |
25,247 | 24,652 | ||||||
| Long-term debt |
41,922 | 40,396 | ||||||
| Other liabilities |
1,543 | 1,427 | ||||||
| Redeemable Equity: |
||||||||
| Preferred stock: |
||||||||
| Series B - 10 shares designated, issued and outstanding, liquidation value of $10 per share |
| | ||||||
| Series C - 588,229 shares designated, none issued or outstanding |
| | ||||||
| Common stock, 1,176,458 shares issued and outstanding |
8,900 | 8,900 | ||||||
| Stockholders Equity: |
||||||||
| Preferred stock, $.01 par value, 1,000,000 shares authorized: |
||||||||
| Series A - 10,000 shares designated, none issued or outstanding |
| | ||||||
| Common stock, $.01 par value, 20,000,000 shares authorized, 4,999,159 shares issued and 4,950,337 outstanding in 2003, and 5,161,013 shares issued and 5,112,191 outstanding in 2004 |
50 | 52 | ||||||
| Additional paid-in capital |
19,803 | 20,966 | ||||||
| Accumulated deficit |
(2,004 | ) | (302 | ) | ||||
| Treasury stock, at cost, 48,822 shares in 2003 and 2004 |
(261 | ) | (261 | ) | ||||
| Accumulated other comprehensive income |
511 | 156 | ||||||
| Total stockholders equity |
18,099 | 20,611 | ||||||
| $ | 95,711 | $ | 95,986 | |||||
See notes to financial statements
OPINION RESEARCH CORPORATION AND SUBSIDIARIES
Consolidated Statements of Operations
(in thousands, except share and per share amounts)
(Unaudited)
| Three Months Ended September 30, |
Nine Months Ended September 30, |
||||||||||||||
| 2003 |
2004 |
2003 |
2004 |
||||||||||||
| Revenues |
$ | 44,867 | $ | 48,894 | $ | 133,512 | $ | 146,255 | |||||||
| Cost of revenues (exclusive of depreciation) |
31,561 | 34,692 | 93,313 | 103,455 | |||||||||||
| Gross profit |
13,306 | 14,202 | 40,199 | 42,800 | |||||||||||
| Selling, general and administrative expenses |
9,542 | 10,130 | 29,192 | 30,398 | |||||||||||
| Depreciation and amortization |
1,018 | 1,017 | 2,972 | 2,914 | |||||||||||
| Operating income |
2,746 | 3,055 | 8,035 | 9,488 | |||||||||||
| Interest expense |
1,247 | 1,167 | 3,541 | 6,540 | |||||||||||
| Other non-operating (income) expenses, net |
(5 | ) | (85 | ) | 12 | (386 | ) | ||||||||
| Income before provision for income taxes |
1,504 | 1,973 | 4,482 | 3,334 | |||||||||||
| Provision for income taxes |
793 | 972 | 2,118 | 1,632 | |||||||||||
| Net income |
$ | 711 | $ | 1,001 | $ | 2,364 | $ | 1,702 | |||||||
| Net income per common share: |
|||||||||||||||
| Basic |
$ | 0.12 | $ | 0.16 | $ | 0.39 | $ | 0.27 | |||||||
| Diluted |
$ | 0.11 | $ | 0.15 | $ | 0.38 | $ | 0.26 | |||||||
| Weighted average common shares outstanding: |
|||||||||||||||
| Basic |
6,090,238 | 6,288,649 | 6,068,134 | 6,226,654 | |||||||||||
| Diluted |
6,323,573 | 6,483,720 | 6,178,744 | 6,435,092 | |||||||||||
See notes to financial statements
| OPINION RESEARCH CORPORATION AND SUBSIDIARIES
Consolidated Statements of Cash Flows (in thousands) (Unaudited) |
| Nine Months Ended September 30, |
||||||||
| 2003 |
2004 |
|||||||
| Cash flows from operating activities: |
||||||||
| Net income |
$ | 2,364 | $ | 1,702 | ||||
| Adjustments to reconcile net income to net cash |
||||||||
| provided by operating activities: |
||||||||
| Depreciation and amortization |
2,972 | 2,914 | ||||||
| Non-cash interest expense |
802 | 3,186 | ||||||
| Other non-cash adjustments |
60 | | ||||||
| Change in: |
||||||||
| Accounts receivable |
389 | (2,949 | ) | |||||
| Other assets |
(659 | ) | (319 | ) | ||||
| Accounts payable and accrued expenses |
647 | (2,805 | ) | |||||
| Deferred revenues |
(924 | ) | 1,183 | |||||
| Other liabilities |
570 | 1,296 | ||||||
| Net cash provided by operating activities |
6,221 | 4,208 | ||||||
| Cash flows from investing activities: |
||||||||
| Capital expenditures |
(2,383 | ) | (3,256 | ) | ||||
| Net cash used in investing activities |
(2,383 | ) | (3,256 | ) | ||||
| Cash flows from financing activities: |
||||||||
| Borrowings under line-of-credit agreements |
33,405 | 51,030 | ||||||
| Repayments under line-of-credit agreements |
(33,180 | ) | (46,523 | ) | ||||
| Issuance of notes payable |
| 22,048 | ||||||
| Repayments of notes payable |
(4,500 | ) | (29,004 | ) | ||||
| Payments of loan origination and amendment fees |
(255 | ) | (1,850 | ) | ||||
| Repayments under capital lease arrangements |
(43 | ) | (79 | ) | ||||
| Proceeds from the issuance of capital stock and exercise of options |
303 | 549 | ||||||
| Net cash used in financing activities |
(4,270 | ) | (3,829 | ) | ||||
| Effect of exchange rate changes on cash and cash equivalents |
34 | 126 | ||||||
| Decrease in cash and cash equivalents |
(398 | ) | (2,751 | ) | ||||
| Cash and cash equivalents at beginning of period |
2,549 | 2,766 | ||||||
| Cash and cash equivalents at end of period |
$ | 2,151 | $ | 15 | ||||
| Non-cash investing and financing activities: |
||||||||
| Acquisition of equipment under capital lease |
$ | 244 | $ | 52 | ||||
See notes to financial statements
OPINION RESEARCH CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements
September 30, 2004
(Unaudited)
NOTE A - BASIS OF PRESENTATION
The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the nine-month period ended September 30, 2004 are not necessarily indicative of the results that may be expected for the full year. For further information, reference should be made to the consolidated financial statements and footnotes contained in our Annual Report on Form 10-K for the year ended December 31, 2003. For purposes of this report, Opinion Research, the Company, we, our, us or similar references means Opinion Research Corporation and its consolidated subsidiaries unless the context requires otherwise.
In the statement of cash flows for the period ended September 30, 2003, $255,000 of the change in other assets previously included in net cash provided by operating activities has been reclassified to payments of loan amendment fees in the cash flows from financing activities to conform to the current period presentation.
NOTE B - CREDIT FACILITIES
In May 2004, we entered into a new secured revolving credit facility of $35.0 million with two financial institutions (the Senior Revolving Facility). The Senior Revolving Facility has a three-year term and is secured by substantially all of the assets of the Company. The Senior Revolving Facility carries an interest rate at the discretion of the Company of either the financial institutions designated base rate (4.75% at September 30, 2004) plus 100 basis points or LIBOR (3-month LIBOR was 2.02% at September 30, 2004) plus 300 basis points. As of September 30, 2004, there was approximately $13.6 million of additional credit available under the Senior Revolving Facility.
In May 2004, we also issued $10.0 million of secured subordinated notes (the Secured Subordinated Notes) and $12.0 million of unsecured subordinated notes (the Unsecured Subordinated Notes) to a financial institution. The Secured Subordinated Notes carry an interest rate of 10% and will mature in November 2007. The Secured Subordinated Notes require principal payments of $500,000 per quarter commencing July 1, 2004, with an unamortized balance of $3.0 million due at the end of the term. The Unsecured Subordinated Notes expire in May 2009 and carry a fixed interest rate of 15.5%; 13% is payable quarterly in cash, and 2.5% may be paid in cash or deferred and included in the outstanding principal balance until maturity. In exchange for consideration received in connection with this debt, we extended the term of existing warrants held by the financial institution from May 2007 to the
later of May 2009 or the third anniversary of the repayment date. These warrants were issued in 1999 to the financial institution and are for the purchase of 437,029 shares of the Companys common stock at an exercise price of $5.422 per share. The extension of these warrants was valued at $616,000 and is being accreted through interest expense over the life of the Unsecured Subordinated Notes.
We are required to maintain certain financial covenants under the credit facilities. For the measuring period ended September 30, 2004, we were in compliance with all of the financial covenants.
All debt outstanding as of May 4, 2004 was repaid with proceeds from the above borrowings. In conjunction with the new credit facilities, we incurred additional costs of approximately $1.4 million which are included in other long term assets in our consolidated financial statements and are amortized over the remaining terms of the facilities. Due to the refinancing of the credit facilities, we also wrote off the unamortized loan fees of approximately $2.5 million as interest expense, which included payments of $420,000 made in 2004, related to the retired debt in the second quarter of 2004.
NOTE C - EARNINGS PER SHARE